AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $13.01 million. The enterprise value is $11.71 million.

Market Cap	13.01M
Enterprise Value	11.71M

Important Dates

The last earnings date was Friday, May 15, 2026, after market close.

Earnings Date	May 15, 2026
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 15.74 million shares outstanding. The number of shares has increased by 313.35% in one year.

Current Share Class	15.74M
Shares Outstanding	15.74M
Shares Change (YoY)	+313.35%
Shares Change (QoQ)	+50.85%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	12.69%
Float	15.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	138.46
Forward PS	n/a
PB Ratio	3.20
P/TBV Ratio	28.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	124.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 2.15.

Current Ratio	1.01
Quick Ratio	0.96
Debt / Equity	2.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.65

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-86.56%
Return on Invested Capital (ROIC)	-239.35%
Return on Capital Employed (ROCE)	-420.94%
Weighted Average Cost of Capital (WACC)	11.55%
Revenue Per Employee	$4,476
Profits Per Employee	-$632,190
Employee Count	21
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.17
52-Week Price Change	n/a
50-Day Moving Average	0.51
200-Day Moving Average	1.38
Relative Strength Index (RSI)	67.75
Average Volume (20 Days)	74,387,888

Short Selling Information

The latest short interest is 303,165, so 1.93% of the outstanding shares have been sold short.

Short Interest	303,165
Short Previous Month	159,719
Short % of Shares Out	1.93%
Short % of Float	1.95%
Short Ratio (days to cover)	1.01

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $94,000 and -$13.28 million in losses. Loss per share was -$6.69.

Revenue	94,000
Gross Profit	-28,000
Operating Income	-10.27M
Pretax Income	-13.28M
Net Income	-13.28M
EBITDA	-10.08M
EBIT	-10.27M
Loss Per Share	-$6.69

Balance Sheet

The company has $5.88 million in cash and $4.57 million in debt, with a net cash position of $1.31 million or $0.08 per share.

Cash & Cash Equivalents	5.88M
Total Debt	4.57M
Net Cash	1.31M
Net Cash Per Share	$0.08
Equity (Book Value)	2.13M
Book Value Per Share	0.26
Working Capital	69,000

Cash Flow

Operating Cash Flow	-11.32M
Capital Expenditures	n/a
Depreciation & Amortization	195,000
Net Borrowing	1.89M
Free Cash Flow	-11.32M
FCF Per Share	-$0.72

Margins

Gross Margin	-29.79%
Operating Margin	-10,926.60%
Pretax Margin	-14,123.40%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-313.35%
Shareholder Yield	-313.35%
Earnings Yield	-102.01%
FCF Yield	-86.94%

Analyst Forecast

The average price target for AIM ImmunoTech is $5.25, which is 535.06% higher than the current price. The consensus rating is "Buy".

Price Target	$5.25
Price Target Difference	535.06%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 9, 2026. It was a forward split with a ratio of 1.001:1.

Last Split Date	Jan 9, 2026
Split Type	Forward
Split Ratio	1.001:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2